-
-
The quality and safety of stroke care in U.S. hospitals can be vastly improved if risk managers first understand how patients may be injured as a result of medical mishaps, according the experience of Strong Memorial Hospital in Rochester, NY.
-
Most ED managers breathed a sigh of relief after The Joint Commission approved an interim action, effective Jan. 1, 2007, that changed the requirement for pharmacy review of ED medication orders [element of performance (EP) 1 for standard 4.10 of medication management].
-
Imagine being in the position of publicly critiquing a competing hospital's compliance with Joint Commission requirements. Would you be able to be completely objective? Even if you were, would your colleagues really trust your ability to be impartial?
-
Just 14 weeks after The Joint Commission approved an interim action that allowed pharmacists to retrospectively review ED medication orders to comply with element of performance (EP) 1 for standard 4.10 of medication management, the action was suspended.
-
It's estimated that 5.5 million workers are potentially exposed to hazardous drugs or drug waste at their worksites, ranging from manufacturing and shipment of the drug to receiving it at a hospital, storing it, delivering it to patients, and disposing of it.
-
When Robert Bray, MD, was asked by a colleague opening a surgery center to move some of his spine procedures to his outpatient center eight years ago, Bray was willing to try a few simple procedures such as microdiscectomies.
-
Shoulder dislocations account for approximately 50% of all dislocations encountered by health care providers. Most dislocations (90-98%) are anterior in nature and result from trauma sustained with the affected extremity abducted and externally rotated.
-
The latest microbicide clinical trials will use antiretroviral therapy (ART), which holds both promise and more challenges for investigators.
-
The Food and Drug Administration (FDA) granted approval, on May 23, 2007, to a generic formulation of zidovudine capsules, 100 mg, manufactured by Cipla Limited, of Mumbai, India.
